• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于识别肥胖青少年代谢功能障碍相关脂肪性肝病(MASLD)的内脏脂肪、人体测量指标和肝功能指标:哪种表现更佳?

Visceral Adiposity, Anthropometric and Liver Function Indexes for Identifying Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD) in Adolescents with Obesity: Which Performs Better?

作者信息

Mari Lara, Lazzer Stefano, Gatti Alessandro, D'Alleva Mattia, Zaccaron Simone, Stafuzza Jacopo, Rejc Enrico, Vandoni Matteo, Bondesan Adele, Caroli Diana, Frigerio Francesca, Abbruzzese Laura, Ventura Enrica, Sartorio Alessandro

机构信息

Department of Medicine, University of Udine, 33100 Udine, Italy.

School of Sport Sciences, University of Udine, 33100 Udine, Italy.

出版信息

J Clin Med. 2025 Mar 19;14(6):2085. doi: 10.3390/jcm14062085.

DOI:10.3390/jcm14062085
PMID:40142893
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11943388/
Abstract

Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD) is the accumulation of fat in the liver without excessive alcohol consumption or other known liver diseases. MASLD is the most common liver disease in adolescents with obesity. The aims of this study were as follows: (i) to determine which index (waist circumference BMI, WHtR, VAI, METS-IR, METS-VF, HSI, FLI, or MetS_zscore) best explains the prevalence of MASLD in adolescents with obesity; (ii) to determine whether there was a specific index that was most strongly associated with MASLD; (iii) to assess which liver function indexes were most strongly correlated with MASLD. A total of 758 adolescents with severe obesity (BMI z-score > 2) admitted at the Division of Auxology, Istituto Auxologico Italiano, IRCCS, Piancavallo-Verbania for a 3-week multidisciplinary body weight reduction program were selected. Anthropometric parameters (stature, body mass, BMI, and waist and hip circumference) were collected, and body composition (lean and fat mass) was determined using the tetrapolar bioimpedance analysis (BIA) technique. Aspartate aminotransferase (AST), alanine aminotransferase (ALT), gamma-glutamyl transferase (gamma GT), alkaline phosphatase (ALP), bilirubin, glucose, total cholesterol, high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), very low-density lipoprotein cholesterol (VLDL-C), triglycerides (TG), and C-reactive protein (CRP) were measured using standard techniques. MASLD was diagnosed based on abdominal ultrasound results. WHtR (65.76%) was the most sensitive compared with other indexes. The HSI (AUC: 0.67 (0.63-0.71, 95% CI), -value < 0.05) showed the best performance in predicting MASLD, with the threshold for having MASLD considered at 48.22. The indexes that showed the worst performance in predicting MASLD were the MetS z-score (AUC: 0.56 (0.52-0.60)) and the VAI (AUC: 0.57 (0.52-0.61)). ALT (OR: 2.92 (2.29-3.77); 95% CI) and AST (OR: 2.52 (2.03-3.20)) were the parameters with a stronger correlation with MASLD. The most sensitive index for diagnosing MASLD was the WHtR, based exclusively on anthropometric parameters. HSI was the index that correlated the most with MASLD, while the parameters of liver function (ALT and AST) were the most strongly correlated with the disease and its severity.

摘要

代谢功能障碍相关脂肪性肝病(MASLD)是指在无过量饮酒或其他已知肝脏疾病的情况下肝脏中脂肪的蓄积。MASLD是肥胖青少年中最常见的肝脏疾病。本研究的目的如下:(i)确定哪个指标(腰围体重指数、腰高比、内脏脂肪指数、代谢综合征胰岛素抵抗指数、代谢综合征内脏脂肪指数、肝脂肪变指数、脂肪肝指数或代谢综合征z评分)能最好地解释肥胖青少年中MASLD的患病率;(ii)确定是否存在与MASLD最密切相关的特定指标;(iii)评估哪些肝功能指标与MASLD的相关性最强。选取了758名重度肥胖青少年(BMI z评分>2),他们因参加为期3周的多学科减重项目而入住意大利IRCCS皮安卡瓦洛-韦尔巴尼亚市意大利辅助学研究所辅助学部。收集了人体测量参数(身高、体重、BMI以及腰围和臀围),并使用四极生物电阻抗分析(BIA)技术测定了身体成分(瘦体重和脂肪量)。使用标准技术测量了天冬氨酸转氨酶(AST)、丙氨酸转氨酶(ALT)、γ-谷氨酰转移酶(γ-GT)、碱性磷酸酶(ALP)、胆红素、葡萄糖、总胆固醇、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)、极低密度脂蛋白胆固醇(VLDL-C)、甘油三酯(TG)和C反应蛋白(CRP)。根据腹部超声结果诊断MASLD。与其他指标相比,腰高比(65.76%)最敏感。肝脂肪变指数(曲线下面积:0.67(0.63 - 0.71,95%置信区间),P值<0.05)在预测MASLD方面表现最佳,将患有MASLD的阈值设定为48.22。在预测MASLD方面表现最差的指标是代谢综合征z评分(曲线下面积:0.56(0.52 - 0.60))和内脏脂肪指数(曲线下面积:0.57(0.52 - 0.61))。ALT(比值比:2.92(2.29 - 3.77);95%置信区间)和AST(比值比:2.52(2.03 - 3.20))是与MASLD相关性更强的参数。仅基于人体测量参数,诊断MASLD最敏感的指标是腰高比。肝脂肪变指数是与MASLD相关性最高的指标,而肝功能参数(ALT和AST)与该疾病及其严重程度的相关性最强。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea35/11943388/bee7bd4fb344/jcm-14-02085-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea35/11943388/1d8f89a14494/jcm-14-02085-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea35/11943388/770f89b039ce/jcm-14-02085-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea35/11943388/bee7bd4fb344/jcm-14-02085-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea35/11943388/1d8f89a14494/jcm-14-02085-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea35/11943388/770f89b039ce/jcm-14-02085-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea35/11943388/bee7bd4fb344/jcm-14-02085-g003.jpg

相似文献

1
Visceral Adiposity, Anthropometric and Liver Function Indexes for Identifying Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD) in Adolescents with Obesity: Which Performs Better?用于识别肥胖青少年代谢功能障碍相关脂肪性肝病(MASLD)的内脏脂肪、人体测量指标和肝功能指标:哪种表现更佳?
J Clin Med. 2025 Mar 19;14(6):2085. doi: 10.3390/jcm14062085.
2
Predicting hepatic steatosis degree in metabolic dysfunction-associated steatotic liver disease using obesity and lipid-related indices.利用肥胖和脂质相关指标预测代谢功能障碍相关脂肪性肝病的肝脂肪变性程度
Sci Rep. 2025 Mar 12;15(1):8612. doi: 10.1038/s41598-024-73132-1.
3
Fatty Liver Index vs. Biochemical-Anthropometric Indices: Diagnosing Metabolic Dysfunction-Associated Steatotic Liver Disease with Non-Invasive Tools.脂肪肝指数与生化-人体测量学指标:使用非侵入性工具诊断代谢功能障碍相关脂肪性肝病
Diagnostics (Basel). 2025 Feb 26;15(5):565. doi: 10.3390/diagnostics15050565.
4
Bioelectrical impedance parameters add incremental value to waist-to-hip ratio for prediction of metabolic dysfunction associated steatotic liver disease in youth with overweight and obesity.生物电阻抗参数为预测超重和肥胖青少年与代谢功能障碍相关的脂肪性肝病增加了腰臀比的附加值。
Front Endocrinol (Lausanne). 2024 May 31;15:1385002. doi: 10.3389/fendo.2024.1385002. eCollection 2024.
5
New indexes of body fat distribution, visceral adiposity index, body adiposity index, waist-to-height ratio, and metabolic disturbances in the obese.肥胖人群中体脂分布的新指标、内脏脂肪指数、身体脂肪指数、腰高比及代谢紊乱
Kardiol Pol. 2017;75(11):1185-1191. doi: 10.5603/KP.a2017.0149. Epub 2017 Jul 17.
6
Association between serum uric acid-to-high-density lipoprotein cholesterol ratio and metabolic dysfunction-associated steatotic liver disease among Chinese children with obesity.中国肥胖儿童血清尿酸与高密度脂蛋白胆固醇比值与代谢功能障碍相关脂肪性肝病的关系
Front Endocrinol (Lausanne). 2025 Jan 8;15:1474384. doi: 10.3389/fendo.2024.1474384. eCollection 2024.
7
The Ability of the Triglyceride-Glucose (TyG) Index and Modified TyG Indexes to Predict the Presence of Metabolic-Associated Fatty Liver Disease and Metabolic Syndrome in a Pediatric Population with Obesity.甘油三酯-葡萄糖(TyG)指数及改良TyG指数预测肥胖儿童人群中代谢相关脂肪性肝病和代谢综合征的能力
J Clin Med. 2025 Mar 28;14(7):2341. doi: 10.3390/jcm14072341.
8
Diagnostic performance of sixteen biomarkers for MASLD: A study in a Mexican cohort.十六种 MASLD 诊断生物标志物的诊断性能:墨西哥队列研究。
Clin Res Hepatol Gastroenterol. 2024 Aug;48(7):102400. doi: 10.1016/j.clinre.2024.102400. Epub 2024 Jun 18.
9
Gender Differences in Liver Steatosis and Fibrosis in Overweight and Obese Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease before and after 8 Weeks of Very Low-Calorie Ketogenic Diet.超重和肥胖代谢功能障碍相关脂肪性肝病患者极低卡路里生酮饮食 8 周前后肝脂肪变性和纤维化的性别差异。
Nutrients. 2024 May 8;16(10):1408. doi: 10.3390/nu16101408.
10
Uric acid as a potential marker of cardiometabolic risk in children and adolescents with metabolic dysfunction associated steatotic liver disease.尿酸作为代谢功能障碍相关脂肪性肝病儿童和青少年心脏代谢风险的潜在标志物。
Clin Exp Hepatol. 2024 Sep;10(3):188-193. doi: 10.5114/ceh.2024.143066. Epub 2024 Sep 30.

引用本文的文献

1
The role of body composition, cardiometabolic parameters, and resting substrate oxidation in protecting against metabolic syndrome in adolescents with obesity.身体成分、心脏代谢参数和静息底物氧化在预防肥胖青少年代谢综合征中的作用。
Front Nutr. 2025 Jul 30;12:1624696. doi: 10.3389/fnut.2025.1624696. eCollection 2025.
2
Association between the dietary index for gut microbiota and all-cause/cardiovascular mortality in patients with metabolic dysfunction-associated steatotic liver disease.肠道微生物群饮食指数与代谢功能障碍相关脂肪性肝病患者全因/心血管死亡率之间的关联
Diabetol Metab Syndr. 2025 Jul 11;17(1):263. doi: 10.1186/s13098-025-01846-x.
3

本文引用的文献

1
Elevated ALT/AST ratio as a marker for NAFLD risk and severity: insights from a cross-sectional analysis in the United States.ALT/AST 比值升高作为非酒精性脂肪性肝病风险和严重程度的标志物:来自美国横断面分析的见解。
Front Endocrinol (Lausanne). 2024 Aug 26;15:1457598. doi: 10.3389/fendo.2024.1457598. eCollection 2024.
2
Global burden of adult non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) has been steadily increasing over the past decades and is expected to persist in the future.在过去几十年中,成人非酒精性脂肪性肝病(NAFLD)和非酒精性脂肪性肝炎(NASH)的全球负担一直在稳步增加,预计未来仍将持续。
Transl Gastroenterol Hepatol. 2024 Jun 24;9:33. doi: 10.21037/tgh-23-118. eCollection 2024.
3
Correlation Between Lipid Accumulation Product and Metabolic Dysfunction-Associated Steatotic Liver Disease in Chinese Adults with Type 2 Diabetes Mellitus.
中国2型糖尿病成年患者中脂质蓄积产物与代谢功能障碍相关脂肪性肝病的相关性
Diabetes Metab Syndr Obes. 2025 Jun 24;18:2007-2017. doi: 10.2147/DMSO.S518649. eCollection 2025.
The newly proposed Metabolic Score for Visceral Fat is a reliable tool for identifying non-alcoholic fatty liver disease, requiring attention to age-specific effects in both sexes.
新提出的代谢性内脏脂肪评分是一种识别非酒精性脂肪肝的可靠工具,需要注意两性的年龄特异性影响。
Front Endocrinol (Lausanne). 2023 Nov 27;14:1281524. doi: 10.3389/fendo.2023.1281524. eCollection 2023.
4
Pathophysiology of obesity and its associated diseases.肥胖及其相关疾病的病理生理学
Acta Pharm Sin B. 2023 Jun;13(6):2403-2424. doi: 10.1016/j.apsb.2023.01.012. Epub 2023 Jan 13.
5
METS-IR vs. HOMA-AD and Metabolic Syndrome in Obese Adolescents.METS-IR 与 HOMA-AD 及肥胖青少年代谢综合征的比较。
J Med Invest. 2023;70(1.2):7-16. doi: 10.2152/jmi.70.7.
6
Prevalence of Elevated ALT in Adolescents in the US 2011-2018.美国 2011-2018 年青少年丙氨酸氨基转移酶升高的流行率。
J Pediatr Gastroenterol Nutr. 2023 Jul 1;77(1):103-109. doi: 10.1097/MPG.0000000000003795. Epub 2023 Apr 21.
7
Variation in Alanine Aminotransferase in Children with Non-Alcoholic Fatty Liver Disease.非酒精性脂肪性肝病患儿丙氨酸氨基转移酶的变化
Children (Basel). 2022 Mar 8;9(3):374. doi: 10.3390/children9030374.
8
Fatty liver index and hypertension-mediated organ damage in never-treated hypertensive patients without diabetes mellitus.非糖尿病未治疗高血压患者中脂肪肝指数与高血压介导的器官损伤。
J Hypertens. 2021 Dec 1;39(12):2470-2477. doi: 10.1097/HJH.0000000000002954.
9
The usefulness of obesity and lipid-related indices to predict the presence of Non-alcoholic fatty liver disease.肥胖和脂质相关指标对预测非酒精性脂肪性肝病的存在的有用性。
Lipids Health Dis. 2021 Oct 10;20(1):134. doi: 10.1186/s12944-021-01561-2.
10
Waist-to-height ratio and non-alcoholic fatty liver disease in adults.腰高比与成年人非酒精性脂肪肝
BMC Gastroenterol. 2021 May 25;21(1):239. doi: 10.1186/s12876-021-01824-3.